<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2018-01-31" version="191">
<accession>Q14654</accession>
<accession>B4DWI4</accession>
<accession>E9PNK0</accession>
<accession>Q2M1H7</accession>
<accession>Q58EX3</accession>
<accession>Q8IW96</accession>
<name>KCJ11_HUMAN</name>
<protein>
<recommendedName>
<fullName>ATP-sensitive inward rectifier potassium channel 11</fullName>
</recommendedName>
<alternativeName>
<fullName>IKATP</fullName>
</alternativeName>
<alternativeName>
<fullName>Inward rectifier K(+) channel Kir6.2</fullName>
</alternativeName>
<alternativeName>
<fullName>Potassium channel, inwardly rectifying subfamily J member 11</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">KCNJ11</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="Science" volume="270" first="1166" last="1170">
<title>Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor.</title>
<authorList>
<person name="Inagaki N."/>
<person name="Gonoi T."/>
<person name="Clement J.P. IV"/>
<person name="Namba N."/>
<person name="Inazawa J."/>
<person name="Gonzalez G."/>
<person name="Aguilar-Bryan L."/>
<person name="Seino S."/>
<person name="Bryan J."/>
</authorList>
<dbReference type="PubMed" id="7502040"/>
<dbReference type="DOI" id="10.1126/science.270.5239.1166"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT SER-148</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Mammary gland</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Nature" volume="440" first="497" last="500">
<title>Human chromosome 11 DNA sequence and analysis including novel gene identification.</title>
<authorList>
<person name="Taylor T.D."/>
<person name="Noguchi H."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Kuroki Y."/>
<person name="Dewar K."/>
<person name="Lloyd C."/>
<person name="Itoh T."/>
<person name="Takeda T."/>
<person name="Kim D.-W."/>
<person name="She X."/>
<person name="Barlow K.F."/>
<person name="Bloom T."/>
<person name="Bruford E."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Eichler E."/>
<person name="FitzGerald M.G."/>
<person name="Jaffe D.B."/>
<person name="LaButti K."/>
<person name="Nicol R."/>
<person name="Park H.-S."/>
<person name="Seaman C."/>
<person name="Sougnez C."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Zody M.C."/>
<person name="Birren B.W."/>
<person name="Nusbaum C."/>
<person name="Fujiyama A."/>
<person name="Hattori M."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Sakaki Y."/>
</authorList>
<dbReference type="PubMed" id="16554811"/>
<dbReference type="DOI" id="10.1038/nature04632"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANTS LYS-23 AND VAL-337</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Ovary</tissue>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1998" name="Circ. Res." volume="83" first="1132" last="1143">
<title>Reconstituted human cardiac KATP channels: functional identity with the native channels from the sarcolemma of human ventricular cells.</title>
<authorList>
<person name="Babenko A.P."/>
<person name="Gonzalez G."/>
<person name="Aguilar-Bryan L."/>
<person name="Bryan J."/>
</authorList>
<dbReference type="PubMed" id="9831708"/>
<dbReference type="DOI" id="10.1161/01.RES.83.11.1132"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ABCC9</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2003" name="Biophys. J." volume="84" first="266" last="276">
<title>Molecular basis for Kir6.2 channel inhibition by adenine nucleotides.</title>
<authorList>
<person name="Ribalet B."/>
<person name="John S.A."/>
<person name="Weiss J.N."/>
</authorList>
<dbReference type="PubMed" id="12524280"/>
<dbReference type="DOI" id="10.1016/S0006-3495(03)74847-4"/>
</citation>
<scope>MOLECULAR BASIS OF ATP SENSITIVITY</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2007" name="Neurology" volume="69" first="1342" last="1349">
<title>A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.</title>
<authorList>
<person name="Shimomura K."/>
<person name="Horster F."/>
<person name="de Wet H."/>
<person name="Flanagan S.E."/>
<person name="Ellard S."/>
<person name="Hattersley A.T."/>
<person name="Wolf N.I."/>
<person name="Ashcroft F."/>
<person name="Ebinger F."/>
</authorList>
<dbReference type="PubMed" id="17652641"/>
<dbReference type="DOI" id="10.1212/01.wnl.0000268488.51776.53"/>
</citation>
<scope>INVOLVEMENT IN PNDM</scope>
<scope>VARIANT PNDM LEU-167</scope>
<scope>CHARACTERIZATION OF VARIANT PNDM LEU-167</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2008" name="J. Clin. Invest." volume="118" first="2877" last="2886">
<title>Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations.</title>
<authorList>
<person name="Pinney S.E."/>
<person name="MacMullen C."/>
<person name="Becker S."/>
<person name="Lin Y.W."/>
<person name="Hanna C."/>
<person name="Thornton P."/>
<person name="Ganguly A."/>
<person name="Shyng S.L."/>
<person name="Stanley C.A."/>
</authorList>
<dbReference type="PubMed" id="18596924"/>
<dbReference type="DOI" id="10.1172/JCI35414"/>
</citation>
<scope>INVOLVEMENT IN HHF2</scope>
<scope>VARIANTS HHF2 LEU-55; ARG-156 AND GLU-204</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2009" name="Hum. Mol. Genet." volume="18" first="2400" last="2413">
<title>Sar1-GTPase-dependent ER exit of KATP channels revealed by a mutation causing congenital hyperinsulinism.</title>
<authorList>
<person name="Taneja T.K."/>
<person name="Mankouri J."/>
<person name="Karnik R."/>
<person name="Kannan S."/>
<person name="Smith A.J."/>
<person name="Munsey T."/>
<person name="Christesen H.B."/>
<person name="Beech D.J."/>
<person name="Sivaprasadarao A."/>
</authorList>
<dbReference type="PubMed" id="19357197"/>
<dbReference type="DOI" id="10.1093/hmg/ddp179"/>
</citation>
<scope>INVOLVEMENT IN HHF2</scope>
<scope>VARIANT HHF2 LYS-282</scope>
<scope>CHARACTERIZATION OF VARIANT HHF2 LYS-282</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2010" name="Hum. Mol. Genet." volume="19" first="963" last="972">
<title>Interaction between mutations in the slide helix of Kir6.2 associated with neonatal diabetes and neurological symptoms.</title>
<authorList>
<person name="Maennikkoe R."/>
<person name="Jefferies C."/>
<person name="Flanagan S.E."/>
<person name="Hattersley A."/>
<person name="Ellard S."/>
<person name="Ashcroft F.M."/>
</authorList>
<dbReference type="PubMed" id="20022885"/>
<dbReference type="DOI" id="10.1093/hmg/ddp554"/>
</citation>
<scope>INVOLVEMENT IN PNDM</scope>
<scope>VARIANTS PNDM TYR-60 AND LEU-64</scope>
<scope>CHARACTERIZATION OF VARIANTS PNDM TYR-60 AND LEU-64</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="Hum. Mutat." volume="13" first="351" last="361">
<title>Congenital hyperinsulinism: molecular basis of a heterogeneous disease.</title>
<authorList>
<person name="Meissner T."/>
<person name="Beinbrech B."/>
<person name="Mayatepek E."/>
</authorList>
<dbReference type="PubMed" id="10338089"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1999)13:5&lt;351::AID-HUMU3>3.0.CO;2-R"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="J. Physiol. (Lond.)" volume="584" first="743" last="753">
<title>A mutation in the ATP-binding site of the Kir6.2 subunit of the KATP channel alters coupling with the SUR2A subunit.</title>
<authorList>
<person name="Tammaro P."/>
<person name="Ashcroft F.M."/>
</authorList>
<dbReference type="PubMed" id="17855752"/>
<dbReference type="DOI" id="10.1113/jphysiol.2007.143149"/>
</citation>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF VARIANT PNDM ILE-333</scope>
<scope>INTERACTION WITH ABCC9</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="Neuroscience" volume="152" first="371" last="380">
<title>Functional modulation of the ATP-sensitive potassium channel by extracellular signal-regulated kinase-mediated phosphorylation.</title>
<authorList>
<person name="Lin Y.F."/>
<person name="Chai Y."/>
</authorList>
<dbReference type="PubMed" id="18280666"/>
<dbReference type="DOI" id="10.1016/j.neuroscience.2008.01.003"/>
</citation>
<scope>PHOSPHORYLATION AT THR-341 AND SER-385</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E37423" last="E37423">
<title>Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene.</title>
<authorList>
<person name="Bonnefond A."/>
<person name="Philippe J."/>
<person name="Durand E."/>
<person name="Dechaume A."/>
<person name="Huyvaert M."/>
<person name="Montagne L."/>
<person name="Marre M."/>
<person name="Balkau B."/>
<person name="Fajardy I."/>
<person name="Vambergue A."/>
<person name="Vatin V."/>
<person name="Delplanque J."/>
<person name="Le Guilcher D."/>
<person name="De Graeve F."/>
<person name="Lecoeur C."/>
<person name="Sand O."/>
<person name="Vaxillaire M."/>
<person name="Froguel P."/>
</authorList>
<dbReference type="PubMed" id="22701567"/>
<dbReference type="DOI" id="10.1371/journal.pone.0037423"/>
</citation>
<scope>INVOLVEMENT IN MODY13</scope>
<scope>VARIANT MODY13 LYS-227</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2017" name="J. Biol. Chem." volume="292" first="17387" last="17398">
<title>Conserved functional consequences of disease-associated mutations in the slide-helix of Kir6.1 and Kir6.2 subunits of the ATP-sensitive potassium channel.</title>
<authorList>
<person name="Cooper P.E."/>
<person name="McClenaghan C."/>
<person name="Chen X."/>
<person name="Stary-Weinzinger A."/>
<person name="Nichols C.G."/>
</authorList>
<dbReference type="PubMed" id="28842488"/>
<dbReference type="DOI" id="10.1074/jbc.M117.804971"/>
</citation>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF VARIANT PNDM LEU-64</scope>
<scope>MUTAGENESIS OF VAL-64</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1995" name="Am. J. Hum. Genet." volume="56" first="416" last="421">
<title>Homozygosity mapping, to chromosome 11p, of the gene for familial persistent hyperinsulinemic hypoglycemia of infancy.</title>
<authorList>
<person name="Thomas P.M."/>
<person name="Cote G.J."/>
<person name="Hallman D.M."/>
<person name="Mathew P.M."/>
</authorList>
<dbReference type="PubMed" id="7847376"/>
</citation>
<scope>VARIANT HHF2 PRO-147</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1996" name="Hum. Mol. Genet." volume="5" first="1809" last="1812">
<title>Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy.</title>
<authorList>
<person name="Thomas P."/>
<person name="Ye Y."/>
<person name="Lightner E."/>
</authorList>
<dbReference type="PubMed" id="8923010"/>
<dbReference type="DOI" id="10.1093/hmg/5.11.1809"/>
</citation>
<scope>VARIANT HHF2 PRO-147</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1996" name="Diabetologia" volume="39" first="1233" last="1236">
<title>Sequence variations in the human Kir6.2 gene, a subunit of the beta-cell ATP-sensitive K-channel: no association with NIDDM in white Caucasian subjects or evidence of abnormal function when expressed in vitro.</title>
<authorList>
<person name="Sakura H."/>
<person name="Wat N."/>
<person name="Horton V."/>
<person name="Millns H."/>
<person name="Turner R.C."/>
<person name="Ashcroft F.M."/>
</authorList>
<dbReference type="PubMed" id="8897013"/>
<dbReference type="DOI" id="10.1007/BF02658512"/>
</citation>
<scope>VARIANTS NIDDM PRO-355 AND LYS-PRO-380 INS</scope>
<scope>VARIANTS LYS-23; VAL-270; VAL-337 AND CYS-385</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1997" name="Diabetes" volume="46" first="502" last="507">
<title>Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM.</title>
<authorList>
<person name="Inoue H."/>
<person name="Ferrer J."/>
<person name="Warren-Perry M."/>
<person name="Zhang Y."/>
<person name="Millns H."/>
<person name="Turner R.C."/>
<person name="Elbein S.C."/>
<person name="Hampe C.L."/>
<person name="Suarez B.K."/>
<person name="Inagaki N."/>
<person name="Seino S."/>
<person name="Permutt M.A."/>
</authorList>
<dbReference type="PubMed" id="9032109"/>
<dbReference type="DOI" id="10.2337/diab.46.3.502"/>
</citation>
<scope>VARIANTS LYS-10; LYS-23; VAL-270 AND VAL-337</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1999" name="Endocr. Rev." volume="20" first="101" last="135">
<title>Molecular biology of adenosine triphosphate-sensitive potassium channels.</title>
<authorList>
<person name="Aguilar-Bryan L."/>
<person name="Bryan J."/>
</authorList>
<dbReference type="PubMed" id="10204114"/>
<dbReference type="DOI" id="10.1210/edrv.20.2.0361"/>
</citation>
<scope>VARIANT HHF2 ARG-91</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1999" name="Nat. Genet." volume="22" first="239" last="247">
<title>Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis.</title>
<authorList>
<person name="Halushka M.K."/>
<person name="Fan J.-B."/>
<person name="Bentley K."/>
<person name="Hsie L."/>
<person name="Shen N."/>
<person name="Weder A."/>
<person name="Cooper R."/>
<person name="Lipshutz R."/>
<person name="Chakravarti A."/>
</authorList>
<dbReference type="PubMed" id="10391210"/>
<dbReference type="DOI" id="10.1038/10297"/>
</citation>
<scope>VARIANTS LYS-23 AND VAL-337</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2002" name="J. Clin. Endocrinol. Metab." volume="87" first="4502" last="4507">
<title>Acute insulin response tests for the differential diagnosis of congenital hyperinsulinism.</title>
<authorList>
<person name="Huopio H."/>
<person name="Jaeaeskelaeinen J."/>
<person name="Komulainen J."/>
<person name="Miettinen R."/>
<person name="Kaerkkaeinen P."/>
<person name="Laakso M."/>
<person name="Tapanainen P."/>
<person name="Voutilainen R."/>
<person name="Otonkoski T."/>
</authorList>
<dbReference type="PubMed" id="12364426"/>
<dbReference type="DOI" id="10.1210/jc.2002-020378"/>
</citation>
<scope>VARIANT HHF2 ASN-67</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2004" name="Diabetes" volume="53" first="2713" last="2718">
<title>Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy.</title>
<authorList>
<person name="Sagen J.V."/>
<person name="Raeder H."/>
<person name="Hathout E."/>
<person name="Shehadeh N."/>
<person name="Gudmundsson K."/>
<person name="Baevre H."/>
<person name="Abuelo D."/>
<person name="Phornphutkul C."/>
<person name="Molnes J."/>
<person name="Bell G.I."/>
<person name="Gloyn A.L."/>
<person name="Hattersley A.T."/>
<person name="Molven A."/>
<person name="Soevik O."/>
<person name="Njoelstad P.R."/>
</authorList>
<dbReference type="PubMed" id="15448106"/>
<dbReference type="DOI" id="10.2337/diabetes.53.10.2713"/>
</citation>
<scope>VARIANTS PNDM VAL-35; MET-59; HIS-201; CYS-330 AND ILE-333</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2004" name="Diabetes" volume="53" first="2719" last="2722">
<title>Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients.</title>
<authorList>
<person name="Vaxillaire M."/>
<person name="Populaire C."/>
<person name="Busiah K."/>
<person name="Cave H."/>
<person name="Gloyn A.L."/>
<person name="Hattersley A.T."/>
<person name="Czernichow P."/>
<person name="Froguel P."/>
<person name="Polak M."/>
</authorList>
<dbReference type="PubMed" id="15448107"/>
<dbReference type="DOI" id="10.2337/diabetes.53.10.2719"/>
</citation>
<scope>VARIANTS PNDM LEU-35; MET-59; CYS-201; HIS-201; LYS-322 AND CYS-330</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="J. Clin. Endocrinol. Metab." volume="89" first="3932" last="3935">
<title>Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel.</title>
<authorList>
<person name="Gloyn A.L."/>
<person name="Cummings E.A."/>
<person name="Edghill E.L."/>
<person name="Harries L.W."/>
<person name="Scott R."/>
<person name="Costa T."/>
<person name="Temple I.K."/>
<person name="Hattersley A.T."/>
<person name="Ellard S."/>
</authorList>
<dbReference type="PubMed" id="15292329"/>
<dbReference type="DOI" id="10.1210/jc.2004-0568"/>
</citation>
<scope>VARIANT PNDM CYS-201</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2004" name="J. Clin. Endocrinol. Metab." volume="89" first="6224" last="6234">
<title>Hyperinsulinism of infancy: novel ABCC8 and KCNJ11 mutations and evidence for additional locus heterogeneity.</title>
<authorList>
<person name="Tornovsky S."/>
<person name="Crane A."/>
<person name="Cosgrove K.E."/>
<person name="Hussain K."/>
<person name="Lavie J."/>
<person name="Heyman M."/>
<person name="Nesher Y."/>
<person name="Kuchinski N."/>
<person name="Ben-Shushan E."/>
<person name="Shatz O."/>
<person name="Nahari E."/>
<person name="Potikha T."/>
<person name="Zangen D."/>
<person name="Tenenbaum-Rakover Y."/>
<person name="de Vries L."/>
<person name="Argente J."/>
<person name="Gracia R."/>
<person name="Landau H."/>
<person name="Eliakim A."/>
<person name="Lindley K."/>
<person name="Dunne M.J."/>
<person name="Aguilar-Bryan L."/>
<person name="Glaser B."/>
</authorList>
<dbReference type="PubMed" id="15579781"/>
<dbReference type="DOI" id="10.1210/jc.2004-1233"/>
</citation>
<scope>VARIANT HHF2 LEU-254</scope>
<scope>CHARACTERIZATION OF VARIANT HHF2 LEU-254</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2004" name="N. Engl. J. Med." volume="350" first="1838" last="1849">
<title>Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.</title>
<authorList>
<person name="Gloyn A.L."/>
<person name="Pearson E.R."/>
<person name="Antcliff J.F."/>
<person name="Proks P."/>
<person name="Bruining G.J."/>
<person name="Slingerland A.S."/>
<person name="Howard N."/>
<person name="Srinivasan S."/>
<person name="Silva J.M.C.L."/>
<person name="Molnes J."/>
<person name="Edghill E.L."/>
<person name="Frayling T.M."/>
<person name="Temple I.K."/>
<person name="Mackay D."/>
<person name="Shield J.P.H."/>
<person name="Sumnik Z."/>
<person name="van Rhijn A."/>
<person name="Wales J.K.H."/>
<person name="Clark P."/>
<person name="Gorman S."/>
<person name="Aisenberg J."/>
<person name="Ellard S."/>
<person name="Njoelstad P.R."/>
<person name="Ashcroft F.M."/>
<person name="Hattersley A.T."/>
</authorList>
<dbReference type="PubMed" id="15115830"/>
<dbReference type="DOI" id="10.1056/NEJMoa032922"/>
</citation>
<scope>VARIANTS PNDM ARG-52; GLY-59; MET-59; HIS-201; CYS-201 AND LEU-296</scope>
<scope>CHARACTERIZATION OF VARIANT PNDM HIS-201</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2004" name="N. Engl. J. Med." volume="351" first="1470" last="1470">
<authorList>
<person name="Gloyn A.L."/>
<person name="Pearson E.R."/>
<person name="Antcliff J.F."/>
<person name="Proks P."/>
<person name="Bruining G.J."/>
<person name="Slingerland A.S."/>
<person name="Howard N."/>
<person name="Srinivasan S."/>
<person name="Silva J.M.C.L."/>
<person name="Molnes J."/>
<person name="Edghill E.L."/>
<person name="Frayling T.M."/>
<person name="Temple I.K."/>
<person name="Mackay D."/>
<person name="Shield J.P.H."/>
<person name="Sumnik Z."/>
<person name="van Rhijn A."/>
<person name="Wales J.K.H."/>
<person name="Clark P."/>
<person name="Gorman S."/>
<person name="Aisenberg J."/>
<person name="Ellard S."/>
<person name="Njoelstad P.R."/>
<person name="Ashcroft F.M."/>
<person name="Hattersley A.T."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="17539" last="17544">
<title>Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.</title>
<authorList>
<person name="Proks P."/>
<person name="Antcliff J.F."/>
<person name="Lippiat J."/>
<person name="Gloyn A.L."/>
<person name="Hattersley A.T."/>
<person name="Ashcroft F.M."/>
</authorList>
<dbReference type="PubMed" id="15583126"/>
<dbReference type="DOI" id="10.1073/pnas.0404756101"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS PNDM ARG-52; GLY-59 AND CYS-201</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2005" name="Clin. Endocrinol. (Oxf.)" volume="62" first="458" last="465">
<title>Genotypes of the pancreatic beta-cell K-ATP channel and clinical phenotypes of Japanese patients with persistent hyperinsulinaemic hypoglycaemia of infancy.</title>
<authorList>
<person name="Ohkubo K."/>
<person name="Nagashima M."/>
<person name="Naito Y."/>
<person name="Taguchi T."/>
<person name="Suita S."/>
<person name="Okamoto N."/>
<person name="Fujinaga H."/>
<person name="Tsumura K."/>
<person name="Kikuchi K."/>
<person name="Ono J."/>
</authorList>
<dbReference type="PubMed" id="15807877"/>
<dbReference type="DOI" id="10.1111/j.1365-2265.2005.02242.x"/>
</citation>
<scope>VARIANT HHF2 HIS-34</scope>
<scope>VARIANTS LYS-23; SER-148 AND VAL-337</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2005" name="Hum. Mol. Genet." volume="14" first="925" last="934">
<title>Relapsing diabetes can result from moderately activating mutations in KCNJ11.</title>
<authorList>
<person name="Gloyn A.L."/>
<person name="Reimann F."/>
<person name="Girard C."/>
<person name="Edghill E.L."/>
<person name="Proks P."/>
<person name="Pearson E.R."/>
<person name="Temple I.K."/>
<person name="Mackay D.J.G."/>
<person name="Shield J.P.H."/>
<person name="Freedenberg D."/>
<person name="Noyes K."/>
<person name="Ellard S."/>
<person name="Ashcroft F.M."/>
<person name="Gribble F.M."/>
<person name="Hattersley A.T."/>
</authorList>
<dbReference type="PubMed" id="15718250"/>
<dbReference type="DOI" id="10.1093/hmg/ddi086"/>
</citation>
<scope>VARIANTS TNDM3 SER-53; ARG-53 AND VAL-182</scope>
<scope>CHARACTERIZATION OF VARIANTS TNDM3 SER-53; ARG-53 AND VAL-182</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2005" name="Hum. Mutat." volume="25" first="22" last="27">
<title>KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes.</title>
<authorList>
<consortium name="The early onset diabetes study group of the Italian society of pediatric endocrinology and diabetes"/>
<person name="Massa O."/>
<person name="Iafusco D."/>
<person name="D'Amato E."/>
<person name="Gloyn A.L."/>
<person name="Hattersley A.T."/>
<person name="Pasquino B."/>
<person name="Tonini G."/>
<person name="Dammacco F."/>
<person name="Zanette G."/>
<person name="Meschi F."/>
<person name="Porzio O."/>
<person name="Bottazzo G."/>
<person name="Crino A."/>
<person name="Lorini R."/>
<person name="Cerutti F."/>
<person name="Vanelli M."/>
<person name="Barbetti F."/>
</authorList>
<dbReference type="PubMed" id="15580558"/>
<dbReference type="DOI" id="10.1002/humu.20124"/>
</citation>
<scope>VARIANTS PNDM PRO-50; MET-59; ARG-170; ASN-170 AND CYS-201</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2005" name="J. Clin. Endocrinol. Metab." volume="90" first="789" last="794">
<title>Genotype-phenotype correlations in children with congenital hyperinsulinism due to recessive mutations of the adenosine triphosphate-sensitive potassium channel genes.</title>
<authorList>
<person name="Henwood M.J."/>
<person name="Kelly A."/>
<person name="MacMullen C."/>
<person name="Bhatia P."/>
<person name="Ganguly A."/>
<person name="Thornton P.S."/>
<person name="Stanley C.A."/>
</authorList>
<dbReference type="PubMed" id="15562009"/>
<dbReference type="DOI" id="10.1210/jc.2004-1604"/>
</citation>
<scope>VARIANTS HHF2 ASP-101; ALA-134; LEU-136; LEU-266 AND HIS-301</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2005" name="J. Clin. Endocrinol. Metab." volume="90" first="3174" last="3178">
<title>The C42R mutation in the Kir6.2 (KCNJ11) gene as a cause of transient neonatal diabetes, childhood diabetes, or later-onset, apparently type 2 diabetes mellitus.</title>
<authorList>
<person name="Yorifuji T."/>
<person name="Nagashima K."/>
<person name="Kurokawa K."/>
<person name="Kawai M."/>
<person name="Oishi M."/>
<person name="Akazawa Y."/>
<person name="Hosokawa M."/>
<person name="Yamada Y."/>
<person name="Inagaki N."/>
<person name="Nakahata T."/>
</authorList>
<dbReference type="PubMed" id="15784703"/>
<dbReference type="DOI" id="10.1210/jc.2005-0096"/>
</citation>
<scope>VARIANT TNDM3 ARG-42</scope>
<scope>CHARACTERIZATION OF VARIANT TNDM3 ARG-42</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2005" name="J. Clin. Endocrinol. Metab." volume="90" first="5401" last="5406">
<title>Severe congenital hyperinsulinism caused by a mutation in the Kir6.2 subunit of the adenosine triphosphate-sensitive potassium channel impairing trafficking and function.</title>
<authorList>
<person name="Marthinet E."/>
<person name="Bloc A."/>
<person name="Oka Y."/>
<person name="Tanizawa Y."/>
<person name="Wehrle-Haller B."/>
<person name="Bancila V."/>
<person name="Dubuis J.-M."/>
<person name="Philippe J."/>
<person name="Schwitzgebel V.M."/>
</authorList>
<dbReference type="PubMed" id="15998776"/>
<dbReference type="DOI" id="10.1210/jc.2005-0202"/>
</citation>
<scope>VARIANT HHF2 ARG-259</scope>
<scope>CHARACTERIZATION OF VARIANT HHF2 ARG-259</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2006" name="Diabetes" volume="55" first="1705" last="1712">
<title>Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects.</title>
<authorList>
<person name="Shimomura K."/>
<person name="Girard C.A.J."/>
<person name="Proks P."/>
<person name="Nazim J."/>
<person name="Lippiat J.D."/>
<person name="Cerutti F."/>
<person name="Lorini R."/>
<person name="Ellard S."/>
<person name="Hattersely A.T."/>
<person name="Barbetti F."/>
<person name="Ashcroft F.M."/>
</authorList>
<dbReference type="PubMed" id="16731833"/>
<dbReference type="DOI" id="10.2337/db05-1640"/>
</citation>
<scope>VARIANTS PNDM GLN-50 AND PRO-50</scope>
<scope>CHARACTERIZATION OF VARIANTS PNDM GLN-50 AND PRO-50</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2006" name="Diabetologia" volume="49" first="1190" last="1197">
<title>Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype.</title>
<authorList>
<person name="Flanagan S.E."/>
<person name="Edghill E.L."/>
<person name="Gloyn A.L."/>
<person name="Ellard S."/>
<person name="Hattersley A.T."/>
</authorList>
<dbReference type="PubMed" id="16609879"/>
<dbReference type="DOI" id="10.1007/s00125-006-0246-z"/>
</citation>
<scope>VARIANTS PNDM TYR-46; GLN-50; ARG-52; ASP-53; GLY-59; MET-59; PRO-164; TYR-166; THR-170; CYS-201; HIS-201; LEU-201; LEU-296 AND SER-330</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2006" name="Hum. Mutat." volume="27" first="214" last="214">
<title>Mutation spectra of ABCC8 gene in Spanish patients with Hyperinsulinism of Infancy (HI).</title>
<authorList>
<person name="Fernandez-Marmiesse A."/>
<person name="Salas A."/>
<person name="Vega A."/>
<person name="Fernandez-Lorenzo J.R."/>
<person name="Barreiro J."/>
<person name="Carracedo A."/>
</authorList>
<dbReference type="PubMed" id="16429405"/>
<dbReference type="DOI" id="10.1002/humu.9401"/>
</citation>
<scope>VARIANTS LYS-23 AND VAL-337</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="3006" last="3012">
<title>A novel KCNJ11 mutation associated with congenital hyperinsulinism reduces the intrinsic open probability of beta-cell ATP-sensitive potassium channels.</title>
<authorList>
<person name="Lin Y.-W."/>
<person name="MacMullen C."/>
<person name="Ganguly A."/>
<person name="Stanley C.A."/>
<person name="Shyng S.-L."/>
</authorList>
<dbReference type="PubMed" id="16332676"/>
<dbReference type="DOI" id="10.1074/jbc.M511875200"/>
</citation>
<scope>VARIANT HHF2 LEU-55</scope>
<scope>CHARACTERIZATION OF VARIANT HHF2 LEU-55</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2006" name="Mod. Pathol." volume="19" first="122" last="129">
<title>Molecular and immunohistochemical analyses of the focal form of congenital hyperinsulinism.</title>
<authorList>
<person name="Suchi M."/>
<person name="MacMullen C.M."/>
<person name="Thornton P.S."/>
<person name="Adzick N.S."/>
<person name="Ganguly A."/>
<person name="Ruchelli E.D."/>
<person name="Stanley C.A."/>
</authorList>
<dbReference type="PubMed" id="16357843"/>
<dbReference type="DOI" id="10.1038/modpathol.3800497"/>
</citation>
<scope>VARIANTS HHF2 ASP-40; ASP-101; PRO-116; LEU-136 AND HIS-301</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2007" name="J. Clin. Endocrinol. Metab." volume="92" first="1276" last="1282">
<title>Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers.</title>
<authorList>
<person name="Stanik J."/>
<person name="Gasperikova D."/>
<person name="Paskova M."/>
<person name="Barak L."/>
<person name="Javorkova J."/>
<person name="Jancova E."/>
<person name="Ciljakova M."/>
<person name="Hlava P."/>
<person name="Michalek J."/>
<person name="Flanagan S.E."/>
<person name="Pearson E."/>
<person name="Hattersley A.T."/>
<person name="Ellard S."/>
<person name="Klimes I."/>
</authorList>
<dbReference type="PubMed" id="17213273"/>
<dbReference type="DOI" id="10.1210/jc.2006-2490"/>
</citation>
<scope>VARIANTS PNDM TYR-46; PRO-164 AND HIS-201</scope>
</reference>
<comment type="function">
<text evidence="1 25 31 37">This receptor is controlled by G proteins. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. Can be blocked by extracellular barium (By similarity). Subunit of ATP-sensitive potassium channels (KATP). Can form cardiac and smooth muscle-type KATP channels with ABCC9. KCNJ11 forms the channel pore while ABCC9 is required for activation and regulation.</text>
</comment>
<comment type="subunit">
<text evidence="25 37">Interacts with ABCC8/SUR. Interacts with ABCC9/SUR2.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2866553"/>
<interactant intactId="EBI-15807650">
<id>Q09428-1</id>
<label>ABCC8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2866553"/>
<interactant intactId="EBI-941975">
<id>Q01484</id>
<label>ANK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Membrane</location>
<topology>Multi-pass membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q14654-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q14654-2</id>
<name>2</name>
<sequence type="described" ref="VSP_045270"/>
</isoform>
</comment>
<comment type="PTM">
<text evidence="26">Phosphorylation by MAPK1 results in changes in channel gating that destabilize the closed states and reduce the ATP sensitivity.</text>
</comment>
<comment type="disease" evidence="2 4 9 10 15 16 17 18 27 28 33 35">
<disease id="DI-01580">
<name>Familial hyperinsulinemic hypoglycemia 2</name>
<acronym>HHF2</acronym>
<description>Most common cause of persistent hypoglycemia in infancy. Unless early and aggressive intervention is undertaken, brain damage from recurrent episodes of hypoglycemia may occur.</description>
<dbReference type="MIM" id="601820"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="5 6 7 8 11 12 21 22 23 24 25 29 31">
<disease id="DI-02152">
<name>Diabetes mellitus, permanent neonatal</name>
<acronym>PNDM</acronym>
<description>A rare form of diabetes distinct from childhood-onset autoimmune diabetes mellitus type 1. It is characterized by insulin-requiring hyperglycemia that is diagnosed within the first months of life. Permanent neonatal diabetes requires lifelong therapy.</description>
<dbReference type="MIM" id="606176"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="13 14">
<disease id="DI-02382">
<name>Transient neonatal diabetes mellitus 3</name>
<acronym>TNDM3</acronym>
<description>Neonatal diabetes mellitus, defined as insulin-requiring hyperglycemia within the first month of life, is a rare entity. In about half of the neonates, diabetes is transient and resolves at a median age of 3 months, whereas the rest have a permanent form of diabetes. In a significant number of patients with transient neonatal diabetes mellitus, diabetes type 2 appears later in life. The onset and severity of TNDM3 is variable with childhood-onset diabetes, gestational diabetes or adult-onset diabetes described.</description>
<dbReference type="MIM" id="610582"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text>Defects in KCNJ11 may contribute to non-insulin-dependent diabetes mellitus (NIDDM), also known as diabetes mellitus type 2.</text>
</comment>
<comment type="disease" evidence="30">
<disease id="DI-04404">
<name>Maturity-onset diabetes of the young 13</name>
<acronym>MODY13</acronym>
<description>A form of diabetes that is characterized by an autosomal dominant mode of inheritance, onset in childhood or early adulthood (usually before 25 years of age), a primary defect in insulin secretion and frequent insulin-independence at the beginning of the disease.</description>
<dbReference type="MIM" id="616329"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="40">Belongs to the inward rectifier-type potassium channel (TC 1.A.2.1) family. KCNJ11 subfamily.</text>
</comment>
<comment type="sequence caution" evidence="40">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAH40617" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<dbReference type="EMBL" id="D50582">
<property type="protein sequence ID" value="BAA09131.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK301550">
<property type="protein sequence ID" value="BAG63046.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC124798">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC064497">
<property type="protein sequence ID" value="AAH64497.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC040617">
<property type="protein sequence ID" value="AAH40617.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC112358">
<property type="protein sequence ID" value="AAI12359.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31436.1">
<molecule id="Q14654-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53606.1">
<molecule id="Q14654-2"/>
</dbReference>
<dbReference type="PIR" id="A57616">
<property type="entry name" value="A57616"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001159762.1">
<property type="nucleotide sequence ID" value="NM_001166290.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.248141"/>
<dbReference type="ProteinModelPortal" id="Q14654"/>
<dbReference type="BioGrid" id="109969">
<property type="interactions" value="12"/>
</dbReference>
<dbReference type="CORUM" id="Q14654"/>
<dbReference type="DIP" id="DIP-58643N"/>
<dbReference type="ELM" id="Q14654"/>
<dbReference type="IntAct" id="Q14654">
<property type="interactions" value="6"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000345708"/>
<dbReference type="BindingDB" id="Q14654"/>
<dbReference type="ChEMBL" id="CHEMBL1886"/>
<dbReference type="DrugBank" id="DB01119">
<property type="generic name" value="Diazoxide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00222">
<property type="generic name" value="Glimepiride"/>
</dbReference>
<dbReference type="DrugBank" id="DB01016">
<property type="generic name" value="Glyburide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00308">
<property type="generic name" value="Ibutilide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00922">
<property type="generic name" value="Levosimendan"/>
</dbReference>
<dbReference type="DrugBank" id="DB01154">
<property type="generic name" value="Thiamylal"/>
</dbReference>
<dbReference type="DrugBank" id="DB00839">
<property type="generic name" value="Tolazamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00661">
<property type="generic name" value="Verapamil"/>
</dbReference>
<dbReference type="DrugBank" id="DB01392">
<property type="generic name" value="Yohimbine"/>
</dbReference>
<dbReference type="TCDB" id="1.A.2.1.17">
<property type="family name" value="the inward rectifier k(+) channel (irk-c) family"/>
</dbReference>
<dbReference type="iPTMnet" id="Q14654"/>
<dbReference type="PhosphoSitePlus" id="Q14654"/>
<dbReference type="BioMuta" id="KCNJ11"/>
<dbReference type="DMDM" id="76803775"/>
<dbReference type="PaxDb" id="Q14654"/>
<dbReference type="PeptideAtlas" id="Q14654"/>
<dbReference type="PRIDE" id="Q14654"/>
<dbReference type="Ensembl" id="ENST00000339994">
<property type="protein sequence ID" value="ENSP00000345708"/>
<property type="gene ID" value="ENSG00000187486"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000528731">
<property type="protein sequence ID" value="ENSP00000434755"/>
<property type="gene ID" value="ENSG00000187486"/>
</dbReference>
<dbReference type="GeneID" id="3767"/>
<dbReference type="KEGG" id="hsa:3767"/>
<dbReference type="UCSC" id="uc001mna.4">
<molecule id="Q14654-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3767"/>
<dbReference type="DisGeNET" id="3767"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000187486.5"/>
<dbReference type="GeneCards" id="KCNJ11"/>
<dbReference type="GeneReviews" id="KCNJ11"/>
<dbReference type="H-InvDB" id="HIX0035982"/>
<dbReference type="HGNC" id="HGNC:6257">
<property type="gene designation" value="KCNJ11"/>
</dbReference>
<dbReference type="HPA" id="HPA048891"/>
<dbReference type="MalaCards" id="KCNJ11"/>
<dbReference type="MIM" id="600937">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="601820">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="606176">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="610582">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="616329">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q14654"/>
<dbReference type="Orphanet" id="276580">
<property type="disease" value="Autosomal dominant hyperinsulinism due to Kir6.2 deficiency"/>
</dbReference>
<dbReference type="Orphanet" id="79644">
<property type="disease" value="Autosomal recessive hyperinsulinism due to Kir6.2 deficiency"/>
</dbReference>
<dbReference type="Orphanet" id="79134">
<property type="disease" value="DEND syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="276603">
<property type="disease" value="Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency"/>
</dbReference>
<dbReference type="Orphanet" id="99989">
<property type="disease" value="Intermediate DEND syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="552">
<property type="disease" value="MODY"/>
</dbReference>
<dbReference type="Orphanet" id="99885">
<property type="disease" value="Permanent neonatal diabetes mellitus"/>
</dbReference>
<dbReference type="Orphanet" id="99886">
<property type="disease" value="Transient neonatal diabetes mellitus"/>
</dbReference>
<dbReference type="PharmGKB" id="PA217"/>
<dbReference type="eggNOG" id="KOG3827">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XQ62">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOGENOM" id="HOG000237325"/>
<dbReference type="HOVERGEN" id="HBG006178"/>
<dbReference type="InParanoid" id="Q14654"/>
<dbReference type="KO" id="K05004"/>
<dbReference type="OrthoDB" id="EOG091G08HC"/>
<dbReference type="PhylomeDB" id="Q14654"/>
<dbReference type="TreeFam" id="TF313676"/>
<dbReference type="Reactome" id="R-HSA-1296025">
<property type="pathway name" value="ATP sensitive Potassium channels"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-382556">
<property type="pathway name" value="ABC-family proteins mediated transport"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-422356">
<property type="pathway name" value="Regulation of insulin secretion"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5578775">
<property type="pathway name" value="Ion homeostasis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5683177">
<property type="pathway name" value="Defective ABCC8 can cause hypoglycemias and hyperglycemias"/>
</dbReference>
<dbReference type="SignaLink" id="Q14654"/>
<dbReference type="SIGNOR" id="Q14654"/>
<dbReference type="GeneWiki" id="Kir6.2"/>
<dbReference type="GenomeRNAi" id="3767"/>
<dbReference type="PRO" id="PR:Q14654"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000187486"/>
<dbReference type="CleanEx" id="HS_KCNJ11"/>
<dbReference type="ExpressionAtlas" id="Q14654">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q14654">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0001669">
<property type="term" value="C:acrosomal vesicle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030673">
<property type="term" value="C:axolemma"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070852">
<property type="term" value="C:cell body fiber"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005768">
<property type="term" value="C:endosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0014704">
<property type="term" value="C:intercalated disc"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008282">
<property type="term" value="C:inward rectifying potassium channel"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043209">
<property type="term" value="C:myelin sheath"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005635">
<property type="term" value="C:nuclear envelope"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030315">
<property type="term" value="C:T-tubule"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030506">
<property type="term" value="F:ankyrin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0015272">
<property type="term" value="F:ATP-activated inward rectifier potassium channel activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031072">
<property type="term" value="F:heat shock protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044325">
<property type="term" value="F:ion channel binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030955">
<property type="term" value="F:potassium ion binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005249">
<property type="term" value="F:voltage-gated potassium channel activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071333">
<property type="term" value="P:cellular response to glucose stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071316">
<property type="term" value="P:cellular response to nicotine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006006">
<property type="term" value="P:glucose metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046676">
<property type="term" value="P:negative regulation of insulin secretion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050877">
<property type="term" value="P:nervous system process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2001259">
<property type="term" value="P:positive regulation of cation channel activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1903078">
<property type="term" value="P:positive regulation of protein localization to plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010107">
<property type="term" value="P:potassium ion import"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071805">
<property type="term" value="P:potassium ion transmembrane transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903779">
<property type="term" value="P:regulation of cardiac conduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050796">
<property type="term" value="P:regulation of insulin secretion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042391">
<property type="term" value="P:regulation of membrane potential"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033198">
<property type="term" value="P:response to ATP"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032355">
<property type="term" value="P:response to estradiol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002931">
<property type="term" value="P:response to ischemia"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033574">
<property type="term" value="P:response to testosterone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0055085">
<property type="term" value="P:transmembrane transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.1400">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR014756">
<property type="entry name" value="Ig_E-set"/>
</dbReference>
<dbReference type="InterPro" id="IPR016449">
<property type="entry name" value="K_chnl_inward-rec_Kir"/>
</dbReference>
<dbReference type="InterPro" id="IPR003279">
<property type="entry name" value="K_chnl_inward-rec_Kir6.2"/>
</dbReference>
<dbReference type="InterPro" id="IPR013518">
<property type="entry name" value="K_chnl_inward-rec_Kir_cyto"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11767">
<property type="entry name" value="PTHR11767"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11767:SF44">
<property type="entry name" value="PTHR11767:SF44"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01007">
<property type="entry name" value="IRK"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF005465">
<property type="entry name" value="GIRK_kir"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01332">
<property type="entry name" value="KIR62CHANNEL"/>
</dbReference>
<dbReference type="PRINTS" id="PR01320">
<property type="entry name" value="KIRCHANNEL"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF81296">
<property type="entry name" value="SSF81296"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0219">Diabetes mellitus</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0407">Ion channel</keyword>
<keyword id="KW-0406">Ion transport</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0630">Potassium</keyword>
<keyword id="KW-0633">Potassium transport</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0851">Voltage-gated channel</keyword>
<feature type="chain" description="ATP-sensitive inward rectifier potassium channel 11" id="PRO_0000154957">
<location>
<begin position="1"/>
<end position="390"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="1">
<location>
<begin position="1"/>
<end position="68"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=M1" evidence="1">
<location>
<begin position="69"/>
<end position="93"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="1">
<location>
<begin position="94"/>
<end position="116"/>
</location>
</feature>
<feature type="intramembrane region" description="Helical; Pore-forming; Name=H5" evidence="1">
<location>
<begin position="117"/>
<end position="128"/>
</location>
</feature>
<feature type="intramembrane region" description="Pore-forming" evidence="1">
<location>
<begin position="129"/>
<end position="135"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="1">
<location>
<begin position="136"/>
<end position="144"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=M2" evidence="1">
<location>
<begin position="145"/>
<end position="166"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="1">
<location>
<begin position="167"/>
<end position="390"/>
</location>
</feature>
<feature type="short sequence motif" description="Selectivity filter" evidence="1">
<location>
<begin position="130"/>
<end position="135"/>
</location>
</feature>
<feature type="site" description="Role in the control of polyamine-mediated channel gating and in the blocking by intracellular magnesium" evidence="1">
<location>
<position position="160"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAPK1" evidence="26">
<location>
<position position="341"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK1" evidence="26">
<location>
<position position="385"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_045270" evidence="38 39">
<location>
<begin position="1"/>
<end position="87"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism." id="VAR_008659" evidence="36">
<original>E</original>
<variation>K</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41309072." id="VAR_055978">
<original>A</original>
<variation>G</variation>
<location>
<position position="18"/>
</location>
</feature>
<feature type="sequence variant" description="Linked to V-337; dbSNP:rs5219." id="VAR_008660" evidence="3 15 19 20 34 36">
<original>E</original>
<variation>K</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="sequence variant" description="In HHF2." id="VAR_031329" evidence="15">
<original>R</original>
<variation>H</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM." id="VAR_026498" evidence="8">
<original>F</original>
<variation>L</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM." id="VAR_026499" evidence="7">
<original>F</original>
<variation>V</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="sequence variant" description="In HHF2." id="VAR_031330" evidence="18">
<original>G</original>
<variation>D</variation>
<location>
<position position="40"/>
</location>
</feature>
<feature type="sequence variant" description="In TNDM3; increased spontaneous open probability; reduced ATP sensitivity; reduced expression at the cell surface of the functional ATP-sensitive form." id="VAR_031331" evidence="14">
<original>C</original>
<variation>R</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM; one patient with mild dysmorphic features." id="VAR_031332" evidence="21 23">
<original>H</original>
<variation>Y</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM; decreased inhibition by ATP; enhanced activation by Mg(2+); increased current; one patient with developmental delay." id="VAR_026500" evidence="11 22">
<original>R</original>
<variation>P</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM; decreased inhibition by ATP; enhanced activation by Mg(2+); increased current." id="VAR_031333" evidence="21 22">
<original>R</original>
<variation>Q</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM; with developmental delay and epilepsy; produces larger current and more change in ATP sensitivity than mutation associated with mild disease C-201." id="VAR_026501" evidence="5 12 21">
<original>Q</original>
<variation>R</variation>
<location>
<position position="52"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM; with developmental delay and epilepsy." id="VAR_031334" evidence="21">
<original>G</original>
<variation>D</variation>
<location>
<position position="53"/>
</location>
</feature>
<feature type="sequence variant" description="In TNDM3; also found in a family member with PNDM; reduction in the sensitivity to ATP when compared with wild-type." id="VAR_026502" evidence="13">
<original>G</original>
<variation>R</variation>
<location>
<position position="53"/>
</location>
</feature>
<feature type="sequence variant" description="In TNDM3; also found in a family member with PNDM; reduction in the sensitivity to ATP when compared with wild-type." id="VAR_026503" evidence="13">
<original>G</original>
<variation>S</variation>
<location>
<position position="53"/>
</location>
</feature>
<feature type="sequence variant" description="In HHF2; does neither affect channel expression nor channel response to MgADP." id="VAR_031335" evidence="17 27">
<original>F</original>
<variation>L</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM; with developmental delay and epilepsy; with neurologic features; produces larger current and more change in ATP sensitivity than mutation associated with mild disease C-201; decreases ATP sensitivity indirectly by favoring the open conformation of the channel." id="VAR_026504" evidence="5 12 21">
<original>V</original>
<variation>G</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM; four patients with developmental delay and muscle weakness." id="VAR_026505" evidence="5 7 8 11 21">
<original>V</original>
<variation>M</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM; found in a patient who also carries L-64 in cis; thought to be the pathogenic mutation in this double allele; displays gain of function; increases the intrinsic channel open probability and decreases sensitivity toward ATP inhibition; variant L-64 associated in cis is thought to ameliorate the effect of the Y-60 mutation on the channel ATP sensitivity." id="VAR_073681" evidence="29">
<original>F</original>
<variation>Y</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM; found in a patient who also carries Y-60 in cis; unknown pathological significance; only subtle effects, if any, on channel ATP sensitivity; thought to attenuate the deleterious effect of the Y-60 mutation associated in cis on the channel ATP sensitivity." id="VAR_073682" evidence="29 31">
<original>V</original>
<variation>L</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="In HHF2." id="VAR_026506" evidence="4">
<original>K</original>
<variation>N</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="sequence variant" description="In HHF2." id="VAR_026507" evidence="2">
<original>W</original>
<variation>R</variation>
<location>
<position position="91"/>
</location>
</feature>
<feature type="sequence variant" description="In HHF2." id="VAR_031336" evidence="9 18">
<original>A</original>
<variation>D</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="sequence variant" description="In HHF2." id="VAR_031337" evidence="18">
<original>S</original>
<variation>P</variation>
<location>
<position position="116"/>
</location>
</feature>
<feature type="sequence variant" description="In HHF2." id="VAR_031338" evidence="9">
<original>G</original>
<variation>A</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="sequence variant" description="In HHF2." id="VAR_031339" evidence="9 18">
<original>R</original>
<variation>L</variation>
<location>
<position position="136"/>
</location>
</feature>
<feature type="sequence variant" description="In HHF2; dbSNP:rs28936678." id="VAR_001557" evidence="33 35">
<original>L</original>
<variation>P</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_031340" evidence="15 32">
<original>I</original>
<variation>S</variation>
<location>
<position position="148"/>
</location>
</feature>
<feature type="sequence variant" description="In HHF2." id="VAR_073683" evidence="27">
<original>G</original>
<variation>R</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM." id="VAR_031341" evidence="21 23">
<original>L</original>
<variation>P</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM; individual also diagnosed with West syndrome." id="VAR_031342" evidence="21">
<original>C</original>
<variation>Y</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM; has severely impaired sensitivity to ATP and markedly increases open channel probability." id="VAR_073684" evidence="24">
<original>I</original>
<variation>L</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM." id="VAR_026508" evidence="11">
<original>K</original>
<variation>N</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM." id="VAR_026509" evidence="11">
<original>K</original>
<variation>R</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM." id="VAR_031343" evidence="21">
<original>K</original>
<variation>T</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In TNDM3; reduction in the sensitivity to ATP when compared with wild-type." id="VAR_026510" evidence="13">
<original>I</original>
<variation>V</variation>
<location>
<position position="182"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5217." id="VAR_014929">
<original>R</original>
<variation>H</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM; two individuals with developmental delay; produces smaller current and less change in ATP sensitivity than mutations associated with severe disease R-52 and G-59." id="VAR_026511" evidence="5 6 8 11 12 21">
<original>R</original>
<variation>C</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM; ability of ATP to block mutant channels greatly reduced." id="VAR_026512" evidence="5 7 8 21 23">
<original>R</original>
<variation>H</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM." id="VAR_031344" evidence="21">
<original>R</original>
<variation>L</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="sequence variant" description="In HHF2." id="VAR_073685" evidence="27">
<original>D</original>
<variation>E</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="sequence variant" description="In MODY13." id="VAR_073686" evidence="30">
<original>E</original>
<variation>K</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In HHF2; impairs trafficking of the mutant channel." id="VAR_026513" evidence="10">
<original>P</original>
<variation>L</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="sequence variant" description="In HHF2; impairs trafficking and abolishes channel function." id="VAR_031345" evidence="16">
<original>H</original>
<variation>R</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence variant" description="In HHF2." id="VAR_031346" evidence="9">
<original>P</original>
<variation>L</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1800467." id="VAR_008661" evidence="34 36">
<original>L</original>
<variation>V</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="sequence variant" description="In HHF2; prevents the ER export and surface expression of the channel." id="VAR_073687" evidence="28">
<original>E</original>
<variation>K</variation>
<location>
<position position="282"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM; with developmental delay and epilepsy." id="VAR_026514" evidence="5 21">
<original>I</original>
<variation>L</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="sequence variant" description="In HHF2." id="VAR_031347" evidence="9 18">
<original>R</original>
<variation>H</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM." id="VAR_026515" evidence="8">
<original>E</original>
<variation>K</variation>
<location>
<position position="322"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM." id="VAR_026516" evidence="7 8">
<original>Y</original>
<variation>C</variation>
<location>
<position position="330"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM." id="VAR_031348" evidence="21">
<original>Y</original>
<variation>S</variation>
<location>
<position position="330"/>
</location>
</feature>
<feature type="sequence variant" description="In PNDM; alters gating characteristics, decreases sensitivity to inhibition by ATP and increases intrinsic open probability." id="VAR_026517" evidence="7 25">
<original>F</original>
<variation>I</variation>
<location>
<position position="333"/>
</location>
</feature>
<feature type="sequence variant" description="Linked to K-23; dbSNP:rs5215." id="VAR_008662" evidence="3 15 19 20 34 36">
<original>I</original>
<variation>V</variation>
<location>
<position position="337"/>
</location>
</feature>
<feature type="sequence variant" description="In NIDDM; Afro-Caribbean." id="VAR_008663" evidence="34">
<original>L</original>
<variation>P</variation>
<location>
<position position="355"/>
</location>
</feature>
<feature type="sequence variant" description="In NIDDM." id="VAR_008664">
<original>P</original>
<variation>PKP</variation>
<location>
<position position="380"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41282930." id="VAR_008665" evidence="34">
<original>S</original>
<variation>C</variation>
<location>
<position position="385"/>
</location>
</feature>
<feature type="mutagenesis site" description="Displays gain of function; increased open state stability, reduced ATP sensitivity and increased channel activity; almost completely abolishes high affinity sensitivity to glibenclamide, an inhibitor of ATP-sensitive potassium channels." evidence="31">
<original>V</original>
<variation>M</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAG63046." ref="2" evidence="40">
<original>K</original>
<variation>E</variation>
<location>
<position position="370"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10204114"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10391210"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12364426"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15115830"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15292329"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15448106"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15448107"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15562009"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15579781"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15580558"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15583126"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15718250"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15784703"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15807877"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15998776"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16332676"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16357843"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16429405"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16554811"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16609879"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16731833"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17213273"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17652641"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17855752"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18280666"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18596924"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19357197"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20022885"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22701567"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28842488"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7502040"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7847376"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8897013"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8923010"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9032109"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9831708"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000305"/>
<sequence length="390" mass="43541" checksum="8345E7DBCE897344" modified="2005-09-27" version="2">
MLSRKGIIPEEYVLTRLAEDPAEPRYRARQRRARFVSKKGNCNVAHKNIREQGRFLQDVF
TTLVDLKWPHTLLIFTMSFLCSWLLFAMAWWLIAFAHGDLAPSEGTAEPCVTSIHSFSSA
FLFSIEVQVTIGFGGRMVTEECPLAILILIVQNIVGLMINAIMLGCIFMKTAQAHRRAET
LIFSKHAVIALRHGRLCFMLRVGDLRKSMIISATIHMQVVRKTTSPEGEVVPLHQVDIPM
ENGVGGNSIFLVAPLIIYHVIDANSPLYDLAPSDLHHHQDLEIIVILEGVVETTGITTQA
RTSYLADEILWGQRFVPIVAEEDGRYSVDYSKFGNTIKVPTPLCTARQLDEDHSLLEALT
LASARGPLRKRSVPMAKAKPKFSISPDSLS
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>